BR0318295A - derivados de sulfamato de benzotiofeno utilizados como inibidores da esteróide sulfatase - Google Patents
derivados de sulfamato de benzotiofeno utilizados como inibidores da esteróide sulfataseInfo
- Publication number
- BR0318295A BR0318295A BRPI0318295-9A BR0318295A BR0318295A BR 0318295 A BR0318295 A BR 0318295A BR 0318295 A BR0318295 A BR 0318295A BR 0318295 A BR0318295 A BR 0318295A
- Authority
- BR
- Brazil
- Prior art keywords
- benzothiophene
- derivatives used
- steroid sulfatase
- sulfatase inhibitors
- sulfamate derivatives
- Prior art date
Links
- OYZCUOMIZVUTQR-UHFFFAOYSA-N 1-benzothiophene;sulfamic acid Chemical class NS(O)(=O)=O.C1=CC=C2SC=CC2=C1 OYZCUOMIZVUTQR-UHFFFAOYSA-N 0.000 title abstract 2
- 229940123142 Steroid sulfatase inhibitor Drugs 0.000 title 1
- 102000009134 Steryl-Sulfatase Human genes 0.000 abstract 1
- 108010087999 Steryl-Sulfatase Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Materials For Photolithography (AREA)
Abstract
"DERIVADOS DO SULFAMATO DE BENZOTIOFENO UTILIZADOS COMO INIBIDORES DA ESTERóIDE SULFATASE". A presente invenção se refere aos compostos do sulfamato de benzotiofeno da fórmula: no qual R~ 1~, R~ 2~, R~ 3~, m e n são definidos na descrição. A invenção se refere igualmente a composições farmacêuticas que contém os ditos compostos e aos métodos de uso destes.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2003/008811 WO2004101545A1 (en) | 2003-05-16 | 2003-05-16 | Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0318295A true BR0318295A (pt) | 2006-07-11 |
Family
ID=33442621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0318295-9A BR0318295A (pt) | 2003-05-16 | 2003-05-16 | derivados de sulfamato de benzotiofeno utilizados como inibidores da esteróide sulfatase |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7476691B2 (pt) |
| EP (1) | EP1644350B1 (pt) |
| JP (1) | JP4757497B2 (pt) |
| CN (2) | CN100491370C (pt) |
| AP (1) | AP2066A (pt) |
| AT (1) | ATE435221T1 (pt) |
| AU (1) | AU2003260390B2 (pt) |
| BR (1) | BR0318295A (pt) |
| CA (1) | CA2525684C (pt) |
| CY (1) | CY1109371T1 (pt) |
| DE (1) | DE60328233D1 (pt) |
| DK (1) | DK1644350T3 (pt) |
| ES (1) | ES2329241T3 (pt) |
| IL (1) | IL171763A (pt) |
| MX (1) | MXPA05012300A (pt) |
| NO (1) | NO20055749L (pt) |
| NZ (1) | NZ544013A (pt) |
| PT (1) | PT1644350E (pt) |
| SI (1) | SI1644350T1 (pt) |
| TN (1) | TNSN05291A1 (pt) |
| WO (1) | WO2004101545A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1890221B (zh) | 2003-12-15 | 2014-07-16 | 沙拉麦斯实验公司 | 1-n-苯基-氨基-1h-咪唑衍生物和含有它们的医药组合物 |
| GB0511190D0 (en) * | 2005-06-01 | 2005-07-06 | Sterix Ltd | Use |
| US20090286863A1 (en) * | 2006-07-05 | 2009-11-19 | David Bruge | Sulfamatobenzothiophene derivatives |
| RU2424237C2 (ru) * | 2006-08-31 | 2011-07-20 | Лаборатуар Терамекс | Сульфаматпроизводные бензотиофена в качестве ингибиторов стероидной сульфатазы |
| EP2086957A1 (de) * | 2006-12-04 | 2009-08-12 | Merck Patent GmbH | Sulfamat-benzothiophen-derivate |
| KR20100068287A (ko) * | 2007-09-17 | 2010-06-22 | 쁘레글렘 에스.아. | 폐경기 전 여성의 에스트로겐 의존성 질환의 치료 |
| JP2011157371A (ja) * | 2011-03-17 | 2011-08-18 | Lab Theramex | ステロイドスルファターゼ阻害剤としてのベンゾチオフェンスルファミン酸塩誘導体 |
| CN115805103B (zh) * | 2021-09-14 | 2024-04-09 | 万华化学集团股份有限公司 | 一种失活钛硅分子筛的再生方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9118478D0 (en) * | 1991-08-29 | 1991-10-16 | Imperial College | Steroid sulphatase inhibitors |
| US6248780B1 (en) | 1998-10-01 | 2001-06-19 | Duquesne University Of The Holy Ghost | Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same |
| JP4320089B2 (ja) * | 1999-07-06 | 2009-08-26 | あすか製薬株式会社 | フェニルスルファメート誘導体 |
-
2003
- 2003-05-16 ES ES03816954T patent/ES2329241T3/es not_active Expired - Lifetime
- 2003-05-16 PT PT03816954T patent/PT1644350E/pt unknown
- 2003-05-16 DK DK03816954T patent/DK1644350T3/da active
- 2003-05-16 CA CA2525684A patent/CA2525684C/en not_active Expired - Fee Related
- 2003-05-16 CN CNB038264706A patent/CN100491370C/zh not_active Expired - Fee Related
- 2003-05-16 WO PCT/EP2003/008811 patent/WO2004101545A1/en not_active Ceased
- 2003-05-16 AT AT03816954T patent/ATE435221T1/de active
- 2003-05-16 JP JP2004571781A patent/JP4757497B2/ja not_active Expired - Fee Related
- 2003-05-16 MX MXPA05012300A patent/MXPA05012300A/es active IP Right Grant
- 2003-05-16 NZ NZ544013A patent/NZ544013A/en not_active IP Right Cessation
- 2003-05-16 DE DE60328233T patent/DE60328233D1/de not_active Expired - Lifetime
- 2003-05-16 CN CNA2009100023017A patent/CN101508691A/zh active Pending
- 2003-05-16 BR BRPI0318295-9A patent/BR0318295A/pt not_active IP Right Cessation
- 2003-05-16 EP EP03816954A patent/EP1644350B1/en not_active Expired - Lifetime
- 2003-05-16 AU AU2003260390A patent/AU2003260390B2/en not_active Ceased
- 2003-05-16 US US10/555,780 patent/US7476691B2/en not_active Expired - Fee Related
- 2003-05-16 SI SI200331665T patent/SI1644350T1/sl unknown
- 2003-05-16 AP AP2005003468A patent/AP2066A/en active
-
2005
- 2005-11-03 IL IL171763A patent/IL171763A/en not_active IP Right Cessation
- 2005-11-15 TN TNP2005000291A patent/TNSN05291A1/en unknown
- 2005-12-05 NO NO20055749A patent/NO20055749L/no not_active Application Discontinuation
-
2009
- 2009-09-09 CY CY20091100937T patent/CY1109371T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1644350A1 (en) | 2006-04-12 |
| ES2329241T3 (es) | 2009-11-24 |
| MXPA05012300A (es) | 2006-01-30 |
| NO20055749D0 (no) | 2005-12-05 |
| US20070021492A1 (en) | 2007-01-25 |
| AU2003260390B2 (en) | 2010-05-20 |
| WO2004101545A1 (en) | 2004-11-25 |
| SI1644350T1 (sl) | 2009-12-31 |
| DE60328233D1 (de) | 2009-08-13 |
| PT1644350E (pt) | 2009-09-02 |
| DK1644350T3 (da) | 2009-11-23 |
| JP2006525947A (ja) | 2006-11-16 |
| ATE435221T1 (de) | 2009-07-15 |
| CN101508691A (zh) | 2009-08-19 |
| CA2525684C (en) | 2015-01-06 |
| AU2003260390A1 (en) | 2004-12-03 |
| NZ544013A (en) | 2009-04-30 |
| CY1109371T1 (el) | 2014-07-02 |
| US7476691B2 (en) | 2009-01-13 |
| CN1771243A (zh) | 2006-05-10 |
| NO20055749L (no) | 2005-12-14 |
| AP2005003468A0 (en) | 2005-12-31 |
| HK1087115A1 (zh) | 2006-10-06 |
| TNSN05291A1 (en) | 2007-07-10 |
| CN100491370C (zh) | 2009-05-27 |
| CA2525684A1 (en) | 2004-11-25 |
| JP4757497B2 (ja) | 2011-08-24 |
| AP2066A (en) | 2009-11-27 |
| EP1644350B1 (en) | 2009-07-01 |
| IL171763A (en) | 2013-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0510273A (pt) | derivados de tetraazabenzo[e]azuleno e análogos destes | |
| BR0314113A (pt) | Derivados de amino propanol | |
| BR0111667A (pt) | Novos compostos | |
| BR0007781A (pt) | Conjugado fisiologicamente ativo, composição, e, processo para a produção de um conjugado de peg-gcsf | |
| BR0113989A (pt) | Compostos, composições farmacêuticas, processo para a preparação de uma composição farmacêutica, e, uso de pelo menos um dos compostos | |
| BRPI0510410A (pt) | compostos orgánicos | |
| BR122019010008B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
| BRPI0112986B8 (pt) | compostos azabicíclicos, processo para a sua preparação, bem como composições farmacêuticas compreendendo os ditos compostos | |
| BR0108678A (pt) | Novos compostos | |
| BRPI0407734A (pt) | derivados de adamantano, processo para sua preparação e composições farmacêuticas os contendo | |
| BR0014279A (pt) | Derivados de piperazina como antagonistas 5-ht1b | |
| ECSP067110A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica | |
| HN2002000300A (es) | Nuevos derivados de piperazina | |
| BR0208741A (pt) | Derivados de piperidina | |
| UY29002A1 (es) | Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
| BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
| BR0311222A (pt) | R-enantiÈmeros de derivados de piranoindol contra hepatite c, seu método de obtenção e composição farmacêutica compreendendo os mesmos | |
| BR0108605A (pt) | Derivados de 8,8a-dihidro-indeno[1,2-d]tiazol, que na posição 8a são substituìdos; processos para a sua preparação e seu emprego como medicamentos, por exemplo, como anoréxicos | |
| BR0307461A (pt) | Derivados de quinazolinona e seu uso como agonistas de cb | |
| BRPI0108990B8 (pt) | processo para preparação de derivados de pirimidona com atividade antifungos | |
| BRPI0712889A8 (pt) | composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica. | |
| BRPI0411092A (pt) | benzo[b]tiofenos substituìdos com 3-arilsulfanila e com 3-heteroarilsulfanila como agentes terapêuticos | |
| BR0318295A (pt) | derivados de sulfamato de benzotiofeno utilizados como inibidores da esteróide sulfatase | |
| BR0012478A (pt) | Derivados de aminotiazóis, sua preparação e composição farmacêuticas contendo os mesmos | |
| BRPI0512986A (pt) | novos derivados de hidantoìna |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |